APA

Farley S., Gottesman M. H., Friedman-Urevich S., Ye J., Shen M., Grueneberg D., Martone L. & Calixte R. (2019). Anti-John Cunningham virus antibody index levels in multiple sclerosis patients treated with rituximab, fingolimod, and dimethyl fumarate. : Surgical neurology international.

Chicago

Farley Stephen, Gottesman Malcolm H, Friedman-Urevich Sharon, Ye Janin, Shen Mark, Grueneberg Denise, Martone Lorraine and Calixte Rose. 2019. Anti-John Cunningham virus antibody index levels in multiple sclerosis patients treated with rituximab, fingolimod, and dimethyl fumarate. : Surgical neurology international.

Harvard

Farley S., Gottesman M. H., Friedman-Urevich S., Ye J., Shen M., Grueneberg D., Martone L. and Calixte R. (2019). Anti-John Cunningham virus antibody index levels in multiple sclerosis patients treated with rituximab, fingolimod, and dimethyl fumarate. : Surgical neurology international.

MLA

Farley Stephen, Gottesman Malcolm H, Friedman-Urevich Sharon, Ye Janin, Shen Mark, Grueneberg Denise, Martone Lorraine and Calixte Rose. Anti-John Cunningham virus antibody index levels in multiple sclerosis patients treated with rituximab, fingolimod, and dimethyl fumarate. : Surgical neurology international. 2019.